Author | Asim Amin, MD, PhD | OncLive

Author | Asim Amin, MD, PhD

Articles

Dr. Amin on CheckMate-214 Trial in RCC

December 06, 2018

Video

Asim Amin, MD, PhD, director of immunotherapy, Levine Cancer Institute, discusses the rationale for the pivotal CheckMate-214 trial in advanced renal cell carcinoma.

Dr. Amin on Evaluating Response to Immunotherapy in RCC

November 03, 2018

Video

Asim Amin, MD, PhD, director of immunotherapy, Levine Cancer Institute, discusses methods of evaluating response to immunotherapy in renal cell carcinoma (RCC).

Dr. Amin on Toxicities With Immunotherapy/TKI Combinations in RCC

October 30, 2018

Video

Asim Amin, MD, PhD, director of immunotherapy, Levine Cancer Institute, discusses how to manage toxicities associated with immunotherapy and tyrosine kinase inhibitor combinations in renal cell carcinoma.

Dr. Amin on Next Steps With Immunotherapy in Advanced RCC

October 24, 2018

Video

Asim Amin, MD, PhD, director of immunotherapy, Levine Cancer Institute, discusses next steps with immunotherapy in the treatment of patients with advanced renal cell carcinoma.

x